GC64989
NAcM-OPT
Also known as 1-benzyl-1-(1-butylpiperidin-4-yl)-3-(3,4-dichlorophenyl)urea
NAcM-OPT is an orally bioavailable cullin neddylation 1 (DCN1) inhibitor, which potently inhibits the DCN1-UBE2M interaction
ChemicalCAS2089293-61-6MW434.4FormulaC23H29Cl2N3O
- CAS number
- 2089293-61-6
- Molecular weight
- 434.4
- Formula
- C23H29Cl2N3O
- Solubility
- DMSO ： 125 mg/mL (287·75 mM; Need ultrasonic)
- InChIKey
- VPHJABWIKCBGMC-UHFFFAOYSA-N
- Catalogue number
- GC64989
- Brand
- GLPBIO
Computed properties PubChem CID 126711307 · XLogP 5.7 · TPSA 35.6 Ų · H-bond donors 1
- XLogP
- 5.7
- TPSA
- 35.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Rotatable bonds
- 7
- Heavy atoms
- 29
SMILES CCCCN1CCC(CC1)N(CC2=CC=CC=C2)C(=O)NC3=CC(=C(C=C3)Cl)Cl
Computed descriptors from PubChem (CID 126711307), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il